Baxion
Screening
Tags
Alerts
Theme
Olema Pharmaceuticals, Inc.
OLMA
·
NASDAQ
·
$13.55
Share Price as of 11/2
·
$1B
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
10-Q
Q2 ended 06/30/26
08/10/26
10-Q
Q1 ended 03/31/26
05/12/26
10-K
FY 2025
03/16/26
10-Q
Q3 ended 09/30/25
11/10/25
10-Q
Q2 ended 06/30/25
08/11/25
Disclosures
Filter
8-K
Current report
10/15/26
8-K
Change in Directors or Officers; Regulation FD Disclosure
08/13/26
8-K
Results of Operations
08/10/26
8-K
Shareholder Vote Results
06/23/26
8-K
Current report
05/26/26
Prospectuses and Registrations
Filter
S-8
Registration of securities for employees
03/16/26
S-3ASR
Automatic shelf registration
12/11/25
424B5
Prospectus supplement
11/19/25
424B5
Prospectus supplement
11/18/25
S-3MEF
Prospectus / registration
11/18/25
Proxies
Filter
DEF 14A
Definitive proxy
04/29/26
DEFA14A
Additional proxy materials
04/29/26
DEF 14A
Definitive proxy
04/28/25
DEFA14A
Additional proxy materials
04/28/25
DEF 14A
Definitive proxy
04/26/24
Ownership
Filter
SC 13D/A
Beneficial ownership (amended)
10/16/26
Form 4
Insider transaction
09/02/26
Form 3
Initial insider ownership
08/13/26
SC 13G/A
Beneficial ownership (amended)
08/06/26
SC 13G/A
Beneficial ownership (amended)
07/29/26
Other
Filter
ARS
Annual report to shareholders
04/29/26
ARS
Annual report to shareholders
04/28/25
EFFECT
Request for effectiveness
01/15/25
EFFECT
Request for effectiveness
01/15/25
CORRESP
Correspondence with the SEC
01/13/25
Latest Filings
Filter
8-K
Current report
10/15/26
8-K
Change in Directors or Officers; Regulation FD Disclosure
08/13/26
10-Q
Q2 ended 06/30/26
08/10/26
8-K
Results of Operations
08/10/26
8-K
Shareholder Vote Results
06/23/26
Ownership
Filter
SC 13D/A
Beneficial ownership (amended)
10/16/26
Form 4
Insider transaction
09/02/26
Form 3
Initial insider ownership
08/13/26
SC 13G/A
Beneficial ownership (amended)
08/06/26
SC 13G/A
Beneficial ownership (amended)
07/29/26